Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01594411 · ClinicalTrials.gov registry record
PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis
A clinical trial, sponsored by CardioDx.
- Completed
- Registry status
- 251
- Enrollment target
NCT01594411: Completed study, sponsored by CardioDx.
NCT01594411 is a clinical trial that has completed, run by CardioDx. The registered enrollment target is 251 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01594411 has completed, sponsored by CardioDx.
- COMPLETED
- Registry status
- 251 participants
- Enrollment target
Study Summary
This is a prospective, multi-center study examining the clinical impact of the Corus CAD (Age/Sex/Gene Expression score - ASGES) assay in approximately 250 evaluable subjects with no history of obstructive coronary artery disease who now present with chest pain or anginal-equivalent symptoms to a primary care physician (PCP) for evaluation.
Primary Outcome
The primary objective was to assess whether the Age/Sex/Gene Expression Score (ASGES) altered clinicians' evaluations, defined by a change in patient management from preliminary to final decision. The change was prospectively defined as a downgrade or upgrade in intensity of the diagnostic plan based on the following hierarchical categories:(1) no further cardiac testing or treatment, (2) lifestyle changes or medical therapy, (3) stress testing (with or without imaging) or computed tomography/co
Interventions
- DIAGNOSTIC_TEST Corus CAD
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 251 participants |
| Start Date | 2012-04 |
| Est. Completion | 2013-02 |
What the finished NCT01594411 record still lists
NCT01594411 is an observational study that tracks outcomes without assigning an intervention. The registered 251 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Corus CAD is the first listed.
NCT01594411 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01594411 about?
NCT01594411 is a clinical study titled "PCP Use of a Gene Expression Test (Corus CAD or ASGES) in Coronary Artery Disease Diagnosis". This is a prospective, multi-center study examining the clinical impact of the Corus CAD (Age/Sex/Gene Expression score - ASGES) assay in approximately 250 evaluable subjects with no history of obstructive coronary artery disease who now present with chest pain or anginal-equivalent symptoms to a pr...
What is the current status of trial NCT01594411?
This trial is currently completed. The enrollment target is 251 participants. The study started on 2012-04. Estimated completion is 2013-02.
What interventions are being tested in trial NCT01594411?
The interventions under investigation include: Corus CAD (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT01594411?
This trial is sponsored by CardioDx, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT06043817 · 251 participants · Phase 1
First-In-Human Study of STX-721/PFL-721 in Participants With Locally Advanced or Metastatic Non-Small Cell Lung Cancer Harboring EGFR or HER2 Exon 20 Insertion Mutations
- NCT02314988 · 252 participants · Phase 2
Tranexamic Acid to Reduce Blood Loss in Spine Surgery
- NCT03941756 · 252 participants · NA
Lymphovenous Bypass Procedure Before Underarm Lymph Node Surgery in Preventing Lymphedema in Patients With Inflammatory or Locally Advanced Non-inflammatory Breast Cancer or Melanoma
- NCT05219617 · 252 participants · Phase 3
Investigate Efficacy and Safety of Carisbamate as Adjunctive Treatment for Seizures Associated With LGS in Children and Adults
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia